2016
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
Morton JM, Shah SN, Wolfe BM, Apovian CM, Miller CJ, Tweden KS, Billington CJ, Shikora SA. Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study. Obesity Surgery 2016, 26: 983-989. PMID: 27048437, PMCID: PMC4831996, DOI: 10.1007/s11695-016-2143-y.Peer-Reviewed Original ResearchConceptsObesity-related comorbid conditionsBody mass indexModerate obesityComorbid conditionsPercentage excess weight lossWeight lossImplant site painVagal nerve blockadeCommon adverse eventsExcess weight lossObesity-related comorbiditiesWeight management counselingType 2 diabetesGreater weight lossSite painAdverse eventsBlockade therapyPrespecified subgroupsSevere obesitySham deviceMass indexNerve blockadeSleep apneaSafety profileClinical trials
2013
Influence of Ethnicity on the Efficacy and Utilization of Bariatric Surgery in the USA
Sudan R, Winegar D, Thomas S, Morton J. Influence of Ethnicity on the Efficacy and Utilization of Bariatric Surgery in the USA. Journal Of Gastrointestinal Surgery 2013, 18: 130-136. PMID: 24101449, DOI: 10.1007/s11605-013-2368-1.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsBlack or African AmericanBody Mass IndexComorbidityDatabases, FactualDiabetes MellitusEthnicityFemaleFollow-Up StudiesGastric BypassGastroesophageal RefluxHealth Status DisparitiesHispanic or LatinoHumansHyperlipidemiasHypertensionLongitudinal StudiesMaleMiddle AgedObesitySleep Apnea, ObstructiveTreatment OutcomeUnited StatesWhite PeopleConceptsBaseline characteristicsThirty-day mortality rateBariatric Outcomes Longitudinal DatabaseGastric bypass surgerySerious adverse eventsPearson's chi-square testChi-square testPatterns of utilizationSmaller percent declineComorbidity burdenBariatric surgeryStudy patientsUnderwent surgeryAdverse eventsBypass surgeryMortality rateInfluence of ethnicityEthnic disparitiesHeavier BMIRYGBSurgeryCategorical variablesComorbiditiesBMIT-test
2011
Short-term medication cost savings for treating hypertension and diabetes after gastric bypass
Ghiassi S, Morton J, Bellatorre N, Eisenberg D. Short-term medication cost savings for treating hypertension and diabetes after gastric bypass. Surgery For Obesity And Related Diseases 2011, 8: 269-274. PMID: 21723203, DOI: 10.1016/j.soard.2011.05.009.Peer-Reviewed Original ResearchConceptsGastric bypass surgerySubset of patientsCost of medicationsBypass surgeryPersistent hypertensionDiabetic medicationsGastric bypassPalo Alto Veterans Affairs Health Care SystemVeterans Affairs Health Care SystemAnnual medication costsPostoperative medication requirementsRemission of diabetesGastric bypass patientsMedication cost savingsTreatment of hypertensionEconomic healthcare burdenHealth care systemAntihypertensive medicationsComplete remissionDiabetes medicationsMedication requirementsProspective databaseBariatric surgeryBypass patientsAnnual cost